P
Peptide Crafters
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A | 10 | 8.3 | 6.4 | 9.0 | 17 Dec 2024 |
| Retatrutide | A | 6 | 7.6 | 6.6 | 9.5 | 17 Dec 2024 |
| Ipamorelin | B | 4 | 6.5 | 6.1 | 7.2 | 27 Feb 2025 |
| Melanotan II | C | 4 | 5.1 | 4.6 | 5.5 | 27 Feb 2025 |
| Tirzepatide | C | 5 | 5.8 | 4.2 | 7.8 | 17 Dec 2024 |
| CJC-1295 | D | 4 | 5.0 | 4.3 | 5.9 | 28 Feb 2025 |
| BPC-157 | D | 6 | 6.6 | 4.0 | 8.9 | 17 Dec 2024 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | A | 2 | 6.2 | 5.6 | 6.7 | 24 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | A | 2 | 6.9 | 5.8 | 8.1 | 24 May 2026 |
| 4-Piperidone CAS 41661-47-6 | A | 2 | 7.6 | 6.9 | 8.3 | 24 May 2026 |
| AHK-CU | A | 3 | 6.0 | 4.8 | 6.9 | 23 May 2026 |
| AICAR | X | 1 | 4.5 | 4.5 | 4.5 | 3 Jun 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | A | 2 | 6.7 | 6.4 | 6.9 | 23 May 2026 |
| BPC157 5mg + TB500 5mg Blend | A | 2 | 6.7 | 5.0 | 8.4 | 24 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | A | 2 | 6.7 | 6.3 | 7.0 | 20 May 2026 |
| Cerebrolysin | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| CJC-1295 With DAC | A | 3 | 6.8 | 5.3 | 8.3 | 26 Jan 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 8.3 | 8.3 | 8.3 | 2 Jul 2025 |
| Clenbuterol | A | 3 | 5.9 | 5.4 | 6.4 | 17 May 2026 |
| Crystagen | A | 2 | 6.6 | 6.2 | 7.0 | 26 Jan 2026 |
| DHB (1-Test Cyp) Oral | A | 2 | 6.7 | 6.4 | 7.0 | 21 May 2026 |
| Dianabol | A | 2 | 6.9 | 6.9 | 6.9 | 17 May 2026 |
| Enclomiphene | A | 3 | 6.6 | 5.3 | 8.0 | 21 May 2026 |
| Finasteride | X | 1 | 7.4 | 7.4 | 7.4 | 2 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 8.9 | 8.9 | 8.9 | 13 Jun 2025 |
| GW-501516 (Cardarine) Raw | X | 1 | 5.6 | 5.6 | 5.6 | 6 May 2025 |
| HMG | X | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 |
| Letrozole | A | 3 | 6.2 | 3.9 | 7.6 | 20 May 2026 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| Methylamine (base) CAS 74-89-5 | A | 2 | 5.8 | 4.7 | 6.8 | 24 May 2026 |
| Methylamine hydrochloride CAS 593-51-1 | X | 1 | 7.6 | 7.6 | 7.6 | 20 Jun 2025 |
| MGF | X | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 |
| NAD+ | A | 2 | 8.6 | 8.1 | 9.2 | 23 May 2026 |
| Ostarine (MK-2866) | A | 2 | 9.1 | 8.4 | 9.7 | 23 May 2026 |
| Oxytocin Acetate | A | 2 | 8.0 | 7.0 | 9.0 | 17 May 2026 |
| P21 | A | 2 | 6.6 | 5.0 | 8.2 | 20 May 2026 |
| PE 22-28 | A | 2 | 7.2 | 5.7 | 8.6 | 23 May 2026 |
| Primobolan Oral (Methenolone Acetate) | X | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 |
| Propionyl chloride CAS 79-03-8 | X | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Prostamax | A | 2 | 4.8 | 4.4 | 5.2 | 21 May 2026 |
| Semax | X | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| SS-31 | X | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 6.1 | 6.1 | 6.1 | 6 May 2025 |
| Vesugen | A | 3 | 6.7 | 6.0 | 7.4 | 25 May 2026 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Oxytocin Acetate | 9.2 | 2mg | 2.1mg | +4.9% | 99.02% | Lab B |
| 25 May 2026 | Vesugen | 7.2 | 20mg | 20.8mg | +3.8% | 96.60% | Lab A |
| 24 May 2026 | 4-Piperidone CAS 41661-47-6 | 6.5 | 1g | 1.2g | +19.3% | 98.98% | Lab G |
| 24 May 2026 | AHK-CU | 6.3 | 30mg | 33.6mg | +12.0% | 98.30% | Lab D |
| 24 May 2026 | AHK-CU | 5.4 | 10mg | 9.3mg | -7.1% | 98.74% | Lab A |
| 24 May 2026 | MGF | 10.0 | 50mg | 54.3mg | +8.6% | 97.59% | Lab D |
| 24 May 2026 | Prostamax | 4.3 | 20mg | 17.3mg | -13.6% | 95.65% | Lab A |
| 24 May 2026 | Prostamax | 4.3 | 50mg | 51.0mg | +2.0% | 97.50% | Lab E |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.9 | 20mg | 19.4mg | -3.2% | 96.21% | Lab F |
| 24 May 2026 | GW-501516 (Cardarine) Raw | 6.1 | 100g | 85.9g | -14.1% | 96.77% | Lab E |
| 24 May 2026 | Propionyl chloride CAS 79-03-8 | 5.5 | 1g | 1.2g | +22.0% | 97.76% | Lab C |
| 24 May 2026 | Semax | 10.0 | 2mg | 1.8mg | -7.8% | 97.65% | Lab A |
| 24 May 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 7.1 | 10g | 9.0g | -10.0% | 95.63% | Lab D |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.2 | 500g | 515.0g | +3.0% | 96.92% | Lab B |
| 24 May 2026 | Crystagen | 6.5 | 2mg | 1.9mg | -2.8% | 97.08% | Lab E |
| 24 May 2026 | Ostarine (MK-2866) | 8.7 | 20mg | 21.9mg | +9.6% | 95.29% | Lab F |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.5 | 50mg | 55.8mg | +11.6% | 99.21% | Lab A |
| 23 May 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 4.9 | 300mg/ml | 363.0mg/ml | +21.0% | 95.80% | Lab F |
| 23 May 2026 | P21 | 6.2 | 50mg | 46.8mg | -6.4% | 96.14% | Lab D |
| 23 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.1 | 2mg | 2.0mg | +1.8% | 96.88% | Lab A |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 9.8 | 1g | 1.1g | +13.3% | 97.58% | Lab A |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.1 | 10mg | 8.7mg | -13.4% | 99.82% | Lab A |
| 21 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.4 | 50mg | 61.8mg | +23.5% | 97.80% | Lab F |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 4.9 | 25mg | 30.7mg | +22.9% | 95.95% | Lab D |
| 21 May 2026 | P21 | 6.4 | 30mg | 27.0mg | -10.0% | 98.91% | Lab C |
| 21 May 2026 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 7.3 | 1g | 1.1g | +11.3% | 98.05% | Lab F |
| 21 May 2026 | PE 22-28 | 5.4 | 30mg | 30.9mg | +3.0% | 98.36% | Lab F |
| 20 May 2026 | Crystagen | 6.0 | 2mg | 2.1mg | +5.7% | 99.26% | Lab E |
| 19 May 2026 | Letrozole | 7.0 | 20mg | 20.0mg | +0.2% | 99.90% | Lab C |
| 19 May 2026 | Methylamine (base) CAS 74-89-5 | 7.5 | 5g | 4.9g | -2.4% | 98.73% | Lab A |
| 17 May 2026 | AICAR | 4.2 | 10mg | 11.7mg | +17.1% | 98.65% | Lab A |
| 17 May 2026 | Enclomiphene | 7.2 | 50mg | 55.4mg | +10.8% | 95.28% | Lab E |
| 29 Jan 2026 | Clenbuterol | 5.4 | 20mg | 19.9mg | -0.7% | 95.55% | Lab G |
| 26 Jan 2026 | Cerebrolysin | 5.9 | 5mg | 6.2mg | +24.9% | 96.61% | Lab D |
| 26 Jan 2026 | DHB (1-Test Cyp) Oral | 8.2 | 50mg | 56.1mg | +12.2% | 95.68% | Lab B |
| 26 Jan 2026 | Enclomiphene | 5.6 | 20mg | 23.7mg | +18.7% | 97.63% | Lab G |
| 19 Jan 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.4 | 1g | 1.2g | +24.4% | 97.17% | Lab G |
| 19 Jan 2026 | CJC-1295 With DAC | 4.7 | 5mg | 5.3mg | +5.6% | 99.61% | Lab D |
| 19 Jan 2026 | Methylamine (base) CAS 74-89-5 | 6.2 | 1g | 0.9g | -9.0% | 98.95% | Lab E |
| 9 Jan 2026 | Dianabol | 7.9 | 100mg | 87.4mg | -12.6% | 96.36% | Lab A |
| 7 Jan 2026 | Enclomiphene | 9.1 | 50mg | 58.6mg | +17.3% | 98.68% | Lab A |
| 7 Jan 2026 | NAD+ | 9.1 | 5mg | 6.1mg | +22.2% | 98.14% | Lab A |
| 6 Jan 2026 | CJC-1295 With DAC | 6.4 | 20mg | 22.4mg | +11.8% | 95.53% | Lab E |
| 6 Jan 2026 | Clenbuterol | 7.3 | 10mg | 10.4mg | +4.2% | 96.98% | Lab D |
| 29 Dec 2025 | BPC-157 | 7.8 | 10mg | (no batch claim) | 11.4mg | 11-18-25 | |
| 16 Dec 2025 | Retatrutide | 9.5 | 15mg | (no batch claim) | 15.6mg | PC-G2-RT15 | |
| 12 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.6 | 15mg | 13.3mg | -11.0% | 97.16% | Lab D |
| 12 Dec 2025 | Ostarine (MK-2866) | 10.0 | 25mg | 24.8mg | -0.9% | 99.08% | Lab D |
| 5 Dec 2025 | Finasteride | 6.5 | 25mg | 28.3mg | +13.3% | 95.58% | Lab D |
| 5 Dec 2025 | HMG | 4.0 | 30mg | 26.1mg | -13.1% | 99.08% | Lab G |
| 23 Nov 2025 | AHK-CU | 5.0 | 2mg | 2.1mg | +3.8% | 98.54% | Lab C |
| 23 Nov 2025 | Dianabol | 5.7 | 50mg | 56.5mg | +12.9% | 98.84% | Lab F |
| 23 Nov 2025 | Letrozole | 5.8 | 50mg | 53.4mg | +6.7% | 98.17% | Lab F |
| 17 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.4 | 2mg | 2.4mg | +20.6% | 98.98% | Lab E |
| 14 Nov 2025 | 4-Piperidone CAS 41661-47-6 | 8.9 | 10g | 11.0g | +9.9% | 98.81% | Lab F |
| 14 Nov 2025 | Clenbuterol | 5.8 | 20mg | 20.1mg | +0.7% | 99.40% | Lab C |
| 14 Nov 2025 | SS-31 | 5.2 | 50mg | 45.1mg | -9.8% | 97.58% | Lab C |
| 5 Nov 2025 | Letrozole | 7.8 | 20mg | 21.7mg | +8.5% | 96.78% | Lab B |
| 5 Nov 2025 | Oxytocin Acetate | 7.5 | 30mg | 28.2mg | -5.8% | 96.17% | Lab A |
| 5 Nov 2025 | PE 22-28 | 8.2 | 50mg | 48.2mg | -3.6% | 96.50% | Lab F |
| 5 Nov 2025 | Vesugen | 6.5 | 5mg | 5.1mg | +2.5% | 97.07% | Lab E |
| 4 Nov 2025 | Methylamine hydrochloride CAS 593-51-1 | 10.0 | 100g | 102.0g | +2.0% | 97.74% | Lab C |
| 4 Nov 2025 | Vesugen | 6.8 | 15mg | 15.3mg | +1.8% | 95.97% | Lab B |
| 17 Oct 2025 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 7.4 | 500g | 472.4g | -5.5% | 97.67% | Lab D |
| 9 Oct 2025 | CJC-1295 With DAC | 5.4 | 50mg | 58.9mg | +17.9% | 96.39% | Lab D |
| 9 Oct 2025 | NAD+ | 7.7 | 10mg | 12.0mg | +20.1% | 98.90% | Lab F |
| 3 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 6.9 | 50mg | 52.2mg | +4.5% | 97.38% | Lab D |
| 20 Mar 2025 | BPC-157 | 5.0 | 10mg | 11.7mgwebsite | 13.75mg | PC-Z1-BP10 | |
| 20 Mar 2025 | Melanotan II | 4.7 | 10mg | 13.0mgwebsite | 8.18mg | PC-Z-MT210 | |
| 20 Mar 2025 | CJC-1295 | DAC | 5.3 | 5mg | 5.2mgwebsite | 4.84mg | PC-Z-CJCDAC |
| 20 Mar 2025 | Semaglutide | 8.9 | 15mg | 16.2mgwebsite | 16.76mg | PC-J-S15 | |
| 20 Mar 2025 | Ipamorelin | 6.6 | 10mg | 13.0mgwebsite | 14.8mg | PC-Z1-IP10 |